Invitrogen Expands High-Throughput Assays With Molecular Probes Purchase
This article was originally published in The Gray Sheet
Executive Summary
Invitrogen will enhance its high-throughput, drug discovery screening assays with Molecular Probes, Inc.'s fluorescent molecular labeling detection systems under a $325 mil. proposed acquisition